Brazil CAR T-Cell Therapy Market Analysis


  • Type: Oncology area
  • Published : May 2021
  • Region: LATAM
  • Country: Brazil
  • Report ID : 4545

  • Format: PPT, PDF

Brazil CAR T-Cell Therapy Market Analysis: Segmented by Product (Allogeneic and Autologous), by Therapy (Axicabtagene ciloleucel and Tisagenlecleucel), and by End User (Cancer Research Centers, Hospitals, Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Contract Research Organizations)– Growth, Trends and Forecast, 2019-2028


Report Overview

The Brazil CAR T-Cell Therapy market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Chimeric Antigen Receptor (CAR) T cell therapy is one type of cancer treatment, which helps to change patients’ T cells so they will attack cancer cells. Firstly, the CAR T cell ingrown in the laboratory, and it was given to patients by infusion. CAR T cells’ distinctive characteristic is to bind to an antigen on the cancer cells and kill them. CAR T cell therapy treatment is mostly used in blood cancer and some, among others. Recently, CAR T cell therapy has been preferred over radiation and chemotherapy.

CAR T cells become activated when targeted over antigen and bind to it to destroy the specific cells. The transfer of T cells is an anti-cancer therapeutic process that focuses virtually on any tumor-associated antigen.

Market Drivers

The industry is being driven by rising government measures to enhance healthcare facilities and promote cancer-cell therapy research.

The government’s increased support in introducing better reimbursement schemes in favour of the poor people is also escalating the market demand. Furthermore, the implementation of procedures with advanced technologies and innovative treatment procedures with fewer side effects are expected to surge the market’s growth rate.

Major CAR T-Cell Therapy Market by Disease Indication

Based on disease indication, the market is segmented into Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma and Others. The Multiple Myeloma sector is leading with the highest shares of the market and is estimated to continue the same growth in the coming years. Multiple myeloma segment has grown in the T cell therapy market. The new acute lymphocytic leukemia and Diffuse large B-cell lymphoma (DLBCL) segment is expected to grow in the coming decades.

1. Brazil CAR T-Cell Therapy Market Overview…………………………………………
A. Market Size
2. Market Growth Drivers …………………………………………………………………..
A. Increase in the number of patients diagnosed with cancer
B. Rising government measures to enhance healthcare facilities and promote cancer-cell therapy research
C. Advanced technologies and Innovative treatment procedures for cancer
3. Major CAR T-Cell Therapy Market by Disease Indication………………………….
A. Diffuse Large B-Cell Lymphoma (DLBCL)
B. Acute Lymphoblastic Leukemia (ALL)
C. Chronic Lymphocytic Leukemia (CLL)
D. Multiple Myeloma (MM)
E. Follicular Lymphoma
F. Others
4. CAR T-Cell Therapy Market Segmentation…………………………………………..
A. By Product
I. Allogeneic
II. Autologous
B. By Therapy
I. Axicabtagene ciloleucel (Yescarta)
II. Tisagenlecleucel (Kymriah)
C. By End User
I. Cancer Research Centers
II. Hospitals
III. Academic and Research Institutes
IV. Pharmaceutical Companies
V. Biotechnology Companies
VI. Contract Research Organizations
5. CAR T-Cell Therapy Major Market Share……………..……………………….
A. Market Analysis, Insights and Forecast—By Revenue
6. Competitive Landscape………………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………………
A. Kite Pharma, Inc Company overview, Product & Services, Strategies & Financials
B. Pfizer Inc. Company overview, Product & Services, Strategies & Financials
C. Novartis International AG Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. Investigation On CAR-T Therapy For The Treatment Of Several Hematologic And Solid Tumour Types
10. Conclusion

Market Segmentation

By Product:

Based on the product, the market is segmented into allogeneic and autologous. The autologous segment is anticipated to lead the CAR T Cell therapy market, which owes to several potential competitors, high costs associated with the market, and a considerable number of key players in the forthcoming years.

By Therapies:

Based on the therapies, the market is segmented into Axicabtagene ciloleucel (Yescarta) and Tisagenlecleucel (Kymriah). The Tisagenlecleucel (Kymriah) segment is expected to account for the largest share in the CAR T cell therapy market. It is due to the increasing occurrence rate of lymphoblastic leukemia and the early accessibility of products that assist in segment growth over the analysis period.

By End User:

Based on the end-user analysis, the market is segmented into cancer research centers, hospitals, academic and research institutes, pharmaceutical companies, biotechnology companies and contract research organizations. The biotechnology and pharmaceutical companies’ segment is witnessed to have a significant share in the market over the period, due to advanced research.

Major Players

Companies playing a leading role in the CAR T cell therapy market are Mustang Bio, Inc., Celgene Corporation, Bluebird Bio, Inc., CARsgen Therapeutics, Ltd., Novartis International AG, Legend Biotech, Sorrento Therapeutics Inc., Kite Pharma, Inc., Immune Therapeutics, Bellicum Pharmaceuticals, Inc. and Pfizer, Inc.

The industry player dominance is because of increased prevalence of cancer coupled with strategic investments and collaborations to proliferate the product portfolio.


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements